ArticleScientific reports2018

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.

Laura Lupini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.